In Vitro and Ex Vivo Modeling of Enteric Bacterial Infections
Overview
Affiliations
Enteric bacterial infections contribute substantially to global disease burden and mortality, particularly in the developing world. 2D monolayer cultures have provided critical insights into the fundamental virulence mechanisms of a multitude of pathogens, including serovars Typhimurium and Typhi, spp., and , which have led to the identification of novel targets for antimicrobial therapy and vaccines. In recent years, the arsenal of experimental systems to study intestinal infections has been expanded by a multitude of more complex models, which have allowed to evaluate the effects of additional physiological and biological parameters on infectivity. Organoids recapitulate the cellular complexity of the human intestinal epithelium while 3D bioengineered scaffolds and microphysiological devices allow to emulate oxygen gradients, flow and peristalsis, as well as the formation and maintenance of stable and physiologically relevant microbial diversity. Additionally, advancements in cultures and intravital imaging have opened new possibilities to study the effects of enteric pathogens on fluid secretion, barrier integrity and immune cell surveillance in the intact intestine. This review aims to present a balanced and updated overview of current intestinal and methods for modeling of enteric bacterial infections. We conclude that the different paradigms are complements rather than replacements and their combined use promises to further our understanding of host-microbe interactions and their impacts on intestinal health.
Current methodologies available to evaluate the virulence potential among clonal complexes.
Sousa M, Magalhaes R, Ferreira V, Teixeira P Front Microbiol. 2024; 15:1425437.
PMID: 39493856 PMC: 11528214. DOI: 10.3389/fmicb.2024.1425437.
An Open-Source 3D-Printed Recording Stage with Customizable Chambers for Ex Vivo Experiments.
Withers P, Morrill H, Parrish R eNeuro. 2024; 11(9).
PMID: 39197950 PMC: 11404268. DOI: 10.1523/ENEURO.0257-24.2024.
Advancements in understanding bacterial enteritis pathogenesis through organoids.
Wu Z, Liu H, Wang X Mol Biol Rep. 2024; 51(1):512.
PMID: 38622483 DOI: 10.1007/s11033-024-09495-5.
Antibiotics for Dyspepsia: Hp, SIBO, IMO, or Something Else?.
Takakura W Dig Dis Sci. 2024; 69(4):1096-1097.
PMID: 38363520 DOI: 10.1007/s10620-024-08281-4.
Kaur R, Kaur K, Alyami M, Kaur Lang D, Saini B, Bayan M Antibiotics (Basel). 2023; 12(5).
PMID: 37237812 PMC: 10215692. DOI: 10.3390/antibiotics12050909.